This bill denies tax credits for health insurance under the Affordable Care Act and Medicaid medical assistance to individuals convicted of sex offenses (as defined by the Adam Walsh Act). Specifically, it amends tax law to block refundable health care credits for sex offenders and adds a Medicaid provision allowing states to exclude sex offenders from receiving government-funded medical coverage. The policy directly affects sex offenders who would otherwise qualify for these federal benefits. The changes apply to tax years and Medicaid enrollments starting after the bill's enactment.
HR 2202 prohibits federal funds from being used for gender transition procedures or health plans covering them in federal programs like Medicaid and the Affordable Care Act. It does not ban these procedures but restricts federal subsidies, requiring individuals to pay for such coverage using non-federal funds (e.g., out-of-pocket or private insurance not tied to federal programs). The bill defines gender transition procedures broadly to include hormonal treatments and surgeries (e.g., mastectomy, hysterectomy), with exceptions for medically necessary treatments related to disorders of sex development or complications from such procedures. It also clarifies that ACA premium tax credits and cost-sharing reductions cannot apply to plans covering these procedures, though separate non-federal-funded coverage remains an option.
This bill would deny federal tax deductions for medical expenses related to gender transition procedures and prohibit federal funding through Medicaid, Medicare, and essential health benefits for such procedures. It defines gender transition procedures broadly to include various hormonal treatments and surgeries, while excluding certain medical conditions like disorders of sex development and specific medical emergencies. The bill would affect individuals seeking gender transition care who rely on federal health programs for coverage. The provisions would apply to services furnished after the bill's enactment, with specific exclusions for certain medically necessary treatments.
This bill prohibits federal funds from covering gender transition procedures in any federal health program, including Medicaid, military health care, and federal employee benefits. It broadly defines "gender transition procedures" to include hormone treatments, surgeries (like hysterectomies or breast implants), and cosmetic procedures, while excluding treatment for disorders of sex development, medical emergencies, or precocious puberty. The bill also modifies the Affordable Care Act to block federal premium tax credits and cost-sharing subsidies for health plans covering these procedures, though it allows states or individuals to pay for separate coverage using non-federal funds. It directly affects federal health programs, Medicaid, and ACA marketplace plans by restricting federal funding for gender transition care.
This bill prohibits federal funding from being used to provide benefits to refugees, asylees, and undocumented immigrants. It specifically blocks funds for programs like Temporary Assistance for Needy Families (TANF), Medicaid, and food stamps (SNAP) when serving these groups, as well as other federal benefits, subsidies, or services. The law directly affects noncitizens in the U.S. without legal status, refugees, and asylees by denying them access to these federal programs. It amends existing law to prevent the use of appropriated funds for these purposes.
Health Care Freedom for Patients Act of 2025 This bill allows certain individuals with health savings accounts (HSAs) to receive federal payments. It also restricts payments under Medicaid and the Children's Health Insurance Program (CHIP) regarding certain noncitizens and restricts coverage of gender-transition procedures. Specifically, the bill provides funds for the Department of Health and Human Services to deposit payments into an individual’s HSA during 2026-2027 if the individual has a bronze or catastrophic plan through a health insurance exchange, is between the ages of 18 and 64, and has income up to 700% of the federal poverty level (FPL). Individuals may receive $1,000 or $1,500 annually, depending on age. The bill also provides funds, beginning in 2027, for cost-sharing reductions for certain individuals who have a silver plan and income up to 250% of the FPL. Beginning in 2027, the bill allows any individual to enroll in a catastrophic plan. Currently, these plans are limited to those under the age of 30 or who have certain exemptions. The bill also reduces the enhanced federal matching rate for the Medicaid expansion population in states that provide any health benefits for individuals who are not qualified aliens under federal law. The bill makes Medicaid and CHIP coverage of individuals while their status is being verified optional and conditions federal payment during this period on verification. Finally, the bill prohibits exchange plans from covering gender-transition procedures as an essential health benefit and prohibits federal payment under Medicaid and CHIP for these procedures.
This bill prohibits federal health programs (Medicare, Medicaid) and private health insurance from covering organ transplants originating in China or not procured through the U.S. Organ Procurement Network, effective January 1, 2026. It defines a "prohibited organ transplant" as one performed in China or using organs not sourced via the U.S. network, including follow-up care like lab tests or drugs. Exceptions only apply to life-saving services provided *after* such a transplant. The law also imposes criminal penalties (up to 2 years in prison) and civil penalties (three times the cost) for violations.
This bill prohibits federal funding from being used to support any healthcare provider that performs abortions, provides abortion referrals, or funds other abortion providers. Exceptions only apply if the pregnancy results from rape or incest, or if a physician certifies that an abortion is necessary to prevent the woman's death. It would take effect 60 days after enactment and apply broadly to all affiliates, subsidiaries, and clinics of such providers. The law would directly affect organizations receiving federal healthcare funds, including Medicaid providers.
This bill would deny federal tax deductions for gender transition procedures and prohibit Medicaid, Medicare, and Children's Health Insurance Program (CHIP) funding for such procedures. It defines gender transition procedures broadly to include hormonal treatments, surgeries, and cosmetic procedures intended to align physical appearance with gender identity, with limited exceptions for medically necessary treatments related to disorders of sex development or life-threatening conditions. The legislation would also require health insurance plans to exclude gender transition procedures from essential health benefits under the Affordable Care Act. This would directly affect individuals seeking gender transition care who rely on federal health programs or tax deductions for medical expenses.
HJRES 58 is a procedural resolution requesting Congress reject a rule issued by the Centers for Medicare & Medicaid Services (CMS) for 2025. The rule would have set payment rates, quality reporting standards, and other policies for home health care services under Medicare, including updates for intravenous immune globulin (IVIG) treatments. This resolution, if passed, would block the CMS rule from taking effect, directly affecting home health care providers and Medicare beneficiaries who rely on these services. It does not create new policy but aims to prevent the implementation of the specific 2025 Medicare home health regulations.
